Mail

UK markets close in 5 hours 11 minutes

FTSE 100
8,115.73
+36.87(+0.46%)
FTSE 250
19,828.56
+226.58(+1.16%)
AIM
755.71
+2.59(+0.34%)
GBP/EUR
1.1660
+0.0003(+0.03%)
GBP/USD
1.2520
+0.0009(+0.07%)
Bitcoin GBP
51,449.88
+500.47(+0.98%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Emergent BioSolutions Inc. (0IGA.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

1.9800

-0.1700

(-7.91%)

As of 07:01PM BST. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	N/A
Enterprise value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	1.19
52-week change ³	-72.60%
S&P500 52-week change ³	21.08%
52-week high ³	13.4182
52-week low ³	0.0000
50-day moving average ³	2.2403
200-day moving average ³	4.1333

Share statistics

Avg vol (3-month) ³	19.43k
Avg vol (10-day) ³	10.76k
Shares outstanding ⁵	50.95M
Implied shares outstanding ⁶	N/A
Float ⁸	51.5M
% held by insiders ¹	1.88%
% held by institutions ¹	78.66%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	N/A
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-72.48%
Operating margin (ttm)	-18.33%

Management effectiveness

Return on assets (ttm)	-4.80%
Return on equity (ttm)	-74.67%

Income statement

Revenue (ttm)	1.05B
Revenue per share (ttm)	20.49
Quarterly revenue growth (yoy)	-16.20%
Gross profit (ttm)	N/A
EBITDA	-70.7M
Net income avi to common (ttm)	-760.5M
Diluted EPS (ttm)	2.9670
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	111.7M
Total cash per share (mrq)	2.14
Total debt (mrq)	877.5M
Total debt/equity (mrq)	135.15%
Current ratio (mrq)	1.04
Book value per share (mrq)	12.44

Cash flow statement

Operating cash flow (ttm)	-206.3M
Levered free cash flow (ttm)	-103.41M